Erkılınç Selçuk, Taylan Enes, Karataşlı Volkan, Uzaldı İpek, Karadeniz Tuğba, Gökçü Mehmet, Sancı Muzaffer
Division of Gynecologic Oncology, University of Medical Sciences Tepecik Education and Research Hospital, Izmir, Turkey.
Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut, USA.
J Obstet Gynaecol Res. 2019 May;45(5):1019-1025. doi: 10.1111/jog.13928. Epub 2019 Feb 13.
To evaluate the effect of lymphadenectomy on surgical morbidity and survival in adult granulosa cell tumor (AGCT) of the ovary.
Patients who underwent surgical treatment for AGCT between January 1993 and January 2016 were identified. Data were collected for patient age, menopausal status, surgical staging, lymphadenectomy, postoperative complications (anemia, wound infection, incisional hernia), length of hospital stay, follow-up duration, site and time for recurrence, management of recurrence and vital status. Histopathological records were also evaluated for number of cellular mitosis.
Lymphadenectomy (pelvic-paraaortic) was performed in 53 (53%) of 98 patients. Decrease in postoperative hemoglobin level and increased wound infection and longer hospital stay were significantly higher in lymphadenectomy group (P = 0.003, 0.043 and <0.001, respectively). Tumor stage (HR 95% CI 14.9 [2.43-92.8]) and number of mitoses >5 (HR 95% CI 14.9 [2.43-92.8]) were significantly associated with recurrence (P = <0.001 and 0.02, respectively). Tumor stage was the only prognostic factor for predicting overall survival (HR 95% CI 8.47 [2.17-33.2]). Lymphadenectomy showed no effect on disease-free survival and overall survival both in multivariate Cox regression analyses (P = 0.46 and 0.69, respectively). Disease-free survival and overall survival were similar in lymphadenectomy and no lymphadenectomy groups (Log Rank P = 0.382, 0.741, respectively).
Lymphadenectomy had no improved effect on survival and had negative effect on surgical morbidity in patients with AGCT.
评估淋巴结切除术对成年卵巢颗粒细胞瘤(AGCT)手术并发症及生存率的影响。
确定1993年1月至2016年1月期间接受AGCT手术治疗的患者。收集患者年龄、绝经状态、手术分期、淋巴结切除术、术后并发症(贫血、伤口感染、切口疝)、住院时间、随访时间、复发部位及时间、复发处理及生存状态等数据。还对组织病理学记录中的细胞有丝分裂数量进行评估。
98例患者中有53例(53%)接受了盆腔-腹主动脉旁淋巴结切除术。淋巴结切除组术后血红蛋白水平下降、伤口感染增加及住院时间延长的情况明显更高(P分别为0.003、0.043和<0.001)。肿瘤分期(HR 95% CI 14.9 [2.43 - 92.8])和有丝分裂数>5(HR 95% CI 14.9 [2.43 - 92.8])与复发显著相关(P分别为<0.001和0.02)。肿瘤分期是预测总生存的唯一预后因素(HR 95% CI 8.47 [2.17 - 33.2])。在多变量Cox回归分析中,淋巴结切除术对无病生存和总生存均无影响(P分别为0.46和0.69)。淋巴结切除组和未进行淋巴结切除组的无病生存和总生存相似(Log Rank P分别为0.382、0.741)。
淋巴结切除术对AGCT患者的生存无改善作用,且对手术并发症有负面影响。